CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0332
-0.0015 (-4.28%)
Sep 15, 2025, 11:29 AM EDT
CV Sciences Revenue
CV Sciences had revenue of $3.62M in the quarter ending June 30, 2025, a decrease of -8.45%. This brings the company's revenue in the last twelve months to $14.98M, down -5.50% year-over-year. In the year 2024, CV Sciences had annual revenue of $15.71M, down -1.87%.
Revenue (ttm)
14.98M
Revenue Growth
-5.50%
P/S Ratio
0.43
Revenue / Employee
311.98K
Employees
49
Market Cap
6.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.71M | -299.00K | -1.87% |
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
CV Sciences News
- 19 days ago - CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & ... - GuruFocus
- 19 days ago - CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus - Accesswire
- 26 days ago - CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - CV Sciences Non-GAAP EPS of $0.00, revenue of $3.62M - Seeking Alpha
- 4 weeks ago - CV Sciences Sales Down 10 Percent - The Motley Fool
- 4 weeks ago - CV Sciences, Inc. Reports Second Quarter 2025 Financial Results - Accesswire
- 5 weeks ago - CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025 - Accesswire
- 2 months ago - Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025 - Benzinga